BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1375486)

  • 1. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
    von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
    Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
    Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
    Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
    von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
    Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
    Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
    Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The present and future of serum diagnostic tests for testicular germ cell tumours.
    Murray MJ; Huddart RA; Coleman N
    Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
    Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
    J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy.
    Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
    Price P; Hogan SJ; Bliss JM; Horwich A
    Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis].
    Canal P; Villeneuve G; Bugat R; Armand JP; Soula G
    Pathol Biol (Paris); 1984 Apr; 32(4):245-50. PubMed ID: 6201806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lactate dehydrogenase (S-LDH) and S-LDH isoenzymes in patients with testicular germ cell tumors.
    von Eyben FE; Skude G; Fosså SD; Klepp O; Børmer O
    Mol Gen Genet; 1983; 189(2):326-33. PubMed ID: 6190072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular cancer. Clinical practice guidelines in oncology.
    Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic factors in metastatic disease.
    Droz JP; Kramar A; Rey A
    Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors in metastatic non-seminomatous germ cell tumours: the Medical Research Council studies.
    Mead GM; Stenning SP
    Eur Urol; 1993; 23(1):196-200; discussion 201. PubMed ID: 7682951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
    Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.